Examples of using Glivec in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
In the Glivec arm, patients were treated with 400 mg daily.
In this study, 14 patients with HES/ CEL weretreated with 100 mg to 1,000 mg of Glivec daily.
Stop Glivec until ANC≥ 1.5 x 109/ l and platelets≥ 75 x 109/ l.
Has been shownto have comparable quality and to be bioequivalent to Glivec.
Follow-up data show that Glivec therapy helped 98% of patients in chronic-phase CML stabilise their blood counts.
This means that because the diseases are rare,it has not been possible to obtain complete information about Glivec.
Glivec will only be prescribed to you by a doctor with experience in medicines to treat blood cancers or solid tumours.
This means that Imatinib medac is similar to a‘reference medicine' already authorised in the European Union(EU)called Glivec.
The estimated rate of progression-freesurvival at 60 months was 83.2% in the Glivec arm and 64.1% in the control arm p< 0.001.
What Glivec looks like and contents of the pack Glivec 100 mg capsules are orange to greyish-orange and marked“ NVR SI”.
This phase III study in adult patients compared treatment with either single-agent Glivec or a combination of interferon-alpha(IFN) plus cytarabine Ara-C.
The experience with Glivec in patients with MDS/ MPD associated with PDGFR gene re-arrangements is very limited see section 5.1.
For MD/ MPD(31 patients), HES and CEL(176 patients), GIST(147 patients) and DFSP(18 patients),the effects of Glivec were not compared to any other medicine.
A further 6 DFSP patients treated with Glivec were reported in 5 published case reports, their ages ranging from 18 months to 49 years.
The Agency's Committee for Medicinal Products for Human Use(CHMP) concluded that, in accordance with EU requirements, Imatinib Teva has beenshown to have comparable quality and to be bioequivalent to Glivec.
The duration of Glivec therapy can vary with the treatment programme selected, but generally longer exposures to Glivec have yielded better results.
Zimmermann and Druker developed a chemical"blocker."It is the main active ingredient in the drug named Glivec, which is now regarded as a"miracle cure" in the fight against CML.
Glivec treatment induces a rapid response in newly diagnosed paediatric CML patients with a CHR of 78% after 8 weeks of therapy.
Active substances that may have their plasma concentration altered by Glivec Imatinib increases the mean Cmax and AUC of simvastatin(CYP3A4 substrate) 2- and 3.5-fold, respectively, indicating an inhibition of the CYP3A4 by imatinib.
Glivec can reduce the number of white cells in the blood, resulting in greater sensitivity to infection.• Unexpected bleeding or bruising in the absence of any injury.
Pretreatment with multiple doses of rifampicin 600 mgfollowed by a single 400 mg dose of Glivec resulted in decrease in Cmax and AUC(0-∞) by at least 54% and 74%, of the respective values without rifampicin treatment.
What Glivec looks like and contents of the pack Glivec 400 mg film-coated tablets are very dark yellow to brownish-orange oval tablets with“ NVR” on one side and“ SL” on the other side.
These enzymes can be found in some receptors on the surface of cancer cells, including the receptorsthat are involved in stimulating the cells to divide uncontrollably in patients with the diseases that Glivec is used to treat.
For ALL, the effects of Glivec were examined in 3 studies including 456 adults, including one study comparing Glivec to standard chemotherapy in 55 newly-diagnosed patients.
If elevations in bilirubin> 3 x institutional upper limit of normal(IULN) or in liver transaminases>5 x IULN occur, Glivec should be withheld until bilirubin levels have returned to< 1.5 x IULN and transaminase levels to< 2.5 x IULN.
What Glivec looks like and contents of the pack Glivec 100 mg film-coated tablets are very dark yellow to brownish-orange round tablets with“ NVR” on one side and“ SA” and a score line on the other side.
In adult and paediatric patients, the effectiveness of Glivec is based on overall haematological and cytogenetic response rates and progression-free survival in CML, on haematological and cytogenetic response rates in Ph+ ALL, MDS/ MPD, on haematological response rates in HES/ CEL and on objective response rates in adult patients with GIST and DFSP.
Glivec is also indicated for the treatment of• adult patients with Kit(CD 117) positive unresectable and/ or metastatic malignant gastrointestinal stromal tumours(GIST).• adult patients with unresectable dermatofibrosarcoma protuberans(DFSP) and adult patients with recurrent and/ or metastatic DFSP who are not eligible for surgery.
On the basis of the existing data, Glivec has been shown to be effective and safe when administered at 600 mg/ day in combination with chemotherapy in the induction phase, the consolidation and maintenance phases of chemotherapy(see section 5.1) for adult patients with newly diagnosed Ph+ ALL.